The enzymology of doxorubicin quinone reduction in tumour tissue
- 1 December 1992
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 44 (11) , 2175-2183
- https://doi.org/10.1016/0006-2952(92)90344-i
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The consequences of doxorubicin quinone reduction in vivo in tumour tissueBiochemical Pharmacology, 1992
- The molecular pharmacology of doxorubicin in vivoEuropean Journal of Cancer and Clinical Oncology, 1991
- Free radicals and anticancer drug resistance: Oxygen free radicals in the mechanisms of drug cytotoxicity and resistance by certain tumorsFree Radical Biology & Medicine, 1990
- Doxorubicin (adriamycin): A critical review of free radical-dependent mechanisms of cytotoxicityPharmacology & Therapeutics, 1990
- The use of electron microscopy and immunocytochemistry to characterise spontaneously-arising, transplantable rat tumorsVirchows Archiv B Cell Pathology Including Molecular Pathology, 1989
- Metabolism and reactions of quinoid anticancer agentsPharmacology & Therapeutics, 1987
- Adriamycin‐loaded albumin microspheres: Preparation, in vivo distribution and release in the ratBiopharmaceutics & Drug Disposition, 1985
- Electrophilic trapping of the tautomer of 7-deoxydaunomycinone. A possible mechanism for covalent binding of daunomycin to DNAJournal of the American Chemical Society, 1983
- DT-diaphorase as a quinone reductase: A cellular control device against semiquinone and superoxide radical formationArchives of Biochemistry and Biophysics, 1982
- Role of one-electron and two-electron reduction products of adriamycin and daunomycin in deoxyribonucleic acid bindingBiochemical Pharmacology, 1981